News Preview
Targeted radioactive therapy may help delay spread of recurrent prostate cancer
A new study suggests that adding a targeted radioactive drug to stereotactic body radiation therapy may help control recurrent prostate cancer longer.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.